Cargando…
Controversies in Clostridium difficile testing
Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135516/ https://www.ncbi.nlm.nih.gov/pubmed/32287670 http://dx.doi.org/10.1016/S0196-4399(02)80020-4 |
_version_ | 1783518073597198336 |
---|---|
author | Fedorko, Daniel P. |
author_facet | Fedorko, Daniel P. |
author_sort | Fedorko, Daniel P. |
collection | PubMed |
description | Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in the institutions they serve. Repeat testing can account for a significant portion of a laboratory's C. difficile testing workload. Published data are available to support laboratory rules for rejection of repeat stool specimens within 7 days of an initial specimen. There are also substantial published data to support laboratory rejection of formed stools sent to the laboratory for C. difficile testing. |
format | Online Article Text |
id | pubmed-7135516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71355162020-04-08 Controversies in Clostridium difficile testing Fedorko, Daniel P. Clin Microbiol Newsl Article Recent reports of two nosocomial outbreaks of Clostridium difficile-associated disease caused by toxin A-deficient strains emphasize that these strains can cause disease. Laboratories using an assay that detects only toxin A as their primary diagnostic test risk misdiagnosis of cases or outbreaks in the institutions they serve. Repeat testing can account for a significant portion of a laboratory's C. difficile testing workload. Published data are available to support laboratory rules for rejection of repeat stool specimens within 7 days of an initial specimen. There are also substantial published data to support laboratory rejection of formed stools sent to the laboratory for C. difficile testing. Published by Elsevier Inc. 2002-05-15 2002-07-25 /pmc/articles/PMC7135516/ /pubmed/32287670 http://dx.doi.org/10.1016/S0196-4399(02)80020-4 Text en Copyright © 2002 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Fedorko, Daniel P. Controversies in Clostridium difficile testing |
title | Controversies in Clostridium difficile testing |
title_full | Controversies in Clostridium difficile testing |
title_fullStr | Controversies in Clostridium difficile testing |
title_full_unstemmed | Controversies in Clostridium difficile testing |
title_short | Controversies in Clostridium difficile testing |
title_sort | controversies in clostridium difficile testing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135516/ https://www.ncbi.nlm.nih.gov/pubmed/32287670 http://dx.doi.org/10.1016/S0196-4399(02)80020-4 |
work_keys_str_mv | AT fedorkodanielp controversiesinclostridiumdifficiletesting |